{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:35:59Z","timestamp":1760204159447},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T00:00:00Z","timestamp":1419811200000},"content-version":"vor","delay-in-days":3103,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1111\/j.1469-0691.2006.01459.x","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T09:12:16Z","timestamp":1147252336000},"page":"666-671","source":"Crossref","is-referenced-by-count":18,"title":["Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy"],"prefix":"10.1016","volume":"12","author":[{"given":"S.","family":"Bertschy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Opravil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cavassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Flepp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-P.","family":"Chave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Christen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2006.01459.x_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS","volume":"15","author":"Luft","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002030-199404000-00010","article-title":"Toxoplasma gondii infection in advanced HIV infection","volume":"8","author":"Oksenhendler","year":"1994","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00005792-199207000-00005","article-title":"Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome","volume":"71","author":"Renold","year":"1992","journal-title":"Medicine"},{"issue":"RR\u201010","key":"10.1111\/j.1469-0691.2006.01459.x_bib4","first-page":"1","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"48","author":"USPHS\/IDSA Prevention of Opportunistic Infections Working Group 1999","year":"1999","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0002-9343(89)90378-1","article-title":"Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome","volume":"86","author":"Cohn","year":"1989","journal-title":"Am J Med"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV\u20101 infected adults treated with combination antiretroviral therapy","volume":"340","author":"Furrer","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib7","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(00)02407-7","article-title":"Stopping primary prophylaxis in HIV\u20101 infected patients at high risk of toxoplasma encephalitis","volume":"335","author":"Furrer","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib8","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among HIV\u2010infected persons \u2013 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America","volume":"51","author":"Kaplan","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib9","first-page":"1","article-title":"Treating opportunistic infections among HIV\u2010infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association\/Infectious Diseases Society of America","volume":"53","author":"Benson","year":"2004","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/00002030-199909100-00007","article-title":"Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?","volume":"13","author":"Kirk","year":"1999","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","article-title":"Discontinuation of secondary prophylaxis for opportunistic infections in HIV\u2010infected patients receiving highly active antiretroviral therapy","volume":"14","author":"Soriano","year":"2000","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/338816","article-title":"Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis","volume":"34","author":"Zeller","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV\u2010associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib14","first-page":"1493","article-title":"Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988\u20132000","volume":"130","author":"Sudre","year":"2000","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042560-199702010-00013","article-title":"Detection of low HIV\u20101 RNA levels in plasma","volume":"14","author":"Schockmel","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archinte.163.10.1220","article-title":"A prospective trial of structured treatment interruptions in human immunodeficiency virus infection","volume":"163","author":"Fagard","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00327535","article-title":"Advantage of magnetic resonance imaging in the diagnosis of cerebral infections","volume":"29","author":"Schroth","year":"1987","journal-title":"Neuroradiology"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0037-198X(99)80026-1","article-title":"Imaging of central nervous system infections","volume":"34","author":"Wong","year":"1999","journal-title":"Semin Roentgenol"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s002340050825","article-title":"MRI of the brain in HIV\u2010positive patients: what is the value of routine intravenous contrast medium?","volume":"41","author":"Malcolm","year":"1999","journal-title":"Neuroradiology"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib20","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/319854","article-title":"Cytomegalovirus (CMV)\u2010specific CD4+ T lymphocyte immune function in long\u2010term survivors of AIDS\u2010related CMV end\u2010organ disease who are receiving potent antiretroviral therapy","volume":"183","author":"Jacobson","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib21","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/320706","article-title":"Immune recovery under highly active antiretroviral therapy is associated with restoration of lymphocyte proliferation and interferon\u2010gamma production in the presence of Toxoplasma gondii antigens","volume":"183","author":"Fournier","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib22","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1128\/IAI.69.5.2920-2927.2001","article-title":"Requirement of non\u2010T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain","volume":"69","author":"Kang","year":"2001","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2006.01459.x_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002030-200001280-00013","article-title":"CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy","volume":"14","author":"Torriani","year":"2000","journal-title":"AIDS"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14642853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14642853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T15:14:58Z","timestamp":1555600498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14642853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1198743X14642853"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01459.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}